BackBionano Genomics Overview

Bionano Genomics Total Assets

Track Bionano Genomics's total assets ($48M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$47.59M
37.39% YoYΔ $-28.42M vs prior year quarter

Peer trimmed avg / median

Loading

Bionano Genomics Total Assets History

Loading

Bionano Genomics vs. peers: Total Assets Comparison

Loading

Bionano Genomics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bionano Genomics (BNGO) FAQ

As of the most recent data (June 2026), BNGO shows a total assets of $48M. That compares with $76M in the prior-year period — down 37.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BNGO's total assets is now $48M (was $76M) — a 37.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bionano Genomics is outperforming or lagging.

Tracking BNGO's total assets over time shows whether Bionano Genomics is scaling, shrinking, or reshaping that part of the business. The current reading is $48M That compares with $76M in the prior-year period — down 37.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Bionano Genomics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $48M) with ownership activity and broader fundamentals.

Bionano Genomics's total assets is $48M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.